Results 151 to 160 of about 5,634,975 (396)
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song +11 more
wiley +1 more source
An ontology for drug-drug interactions [PDF]
Proceedings of: The 6th International Workshop on Semantic Web Applications and Tools for Life Sciences (SWAT4LS 2013). Took place 2013, December 11-12, in Edinburgh, UK.
Croset, Samuel +5 more
core +3 more sources
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton +17 more
wiley +1 more source
Drug–Drug Interactions Of Amiodarone And Quinidine On The Pharmacokinetics Of Eliglustat In Rats
Qiong Wang,1 Haiyun Wang,1 Youyan Zhong,1 Qiang Zhang2 1Department of Pharmacy, Wenzhou People’s Hospital, Wenzhou, Zhejiang 325000, People’s Republic of China; 2Department of Clinical Laboratory, The People’s Hospital of Lishui, Lishui,
Wang Q, Wang H, Zhong Y, Zhang Q
doaj
Psychotropic Drugs (2) Interaction between Monoamine Oxidase (MAO) Inhibitors and other Substances [PDF]
Folke Sjöqvist
openalex +1 more source
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop +10 more
wiley +1 more source
Drug–Drug Interactions of FXI Inhibitors: Clinical Relevance
Inhibitors of the factor FXI represent a new class of anticoagulant agents that are facing clinical approval for the treatment of acute coronary syndrome (ACS), venous thromboembolism (VTE), and stroke prevention of atrial fibrillation (AF).
Nicola Ferri +2 more
doaj +1 more source
The Interaction of Anesthetic Agents and Adrenergic Drugs to Produce Cardiac Arrhythmias [PDF]
Ronald L. Katz, Ralph Epstein
openalex +1 more source
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed +8 more
wiley +1 more source
THE INTERACTION OF SOME STIMULANT AND DEPRESSANT DRUGS ON THE FROG HEART [PDF]
J. L. BROADBENT
openalex +1 more source

